Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 3
2007 4
2008 6
2010 8
2011 5
2012 18
2013 10
2014 12
2015 16
2016 18
2017 24
2018 7
2019 8
2020 5
2021 11
2022 7
2023 12
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

163 results

Results by year

Filters applied: . Clear all
Page 1
Lenvatinib as an Initial Treatment in Patients with Intermediate-Stage Hepatocellular Carcinoma Beyond Up-To-Seven Criteria and Child-Pugh A Liver Function: A Proof-Of-Concept Study.
Kudo M, Ueshima K, Chan S, Minami T, Chishina H, Aoki T, Takita M, Hagiwara S, Minami Y, Ida H, Takenaka M, Sakurai T, Watanabe T, Morita M, Ogawa C, Wada Y, Ikeda M, Ishii H, Izumi N, Nishida N. Kudo M, et al. Among authors: hagiwara s. Cancers (Basel). 2019 Jul 31;11(8):1084. doi: 10.3390/cancers11081084. Cancers (Basel). 2019. PMID: 31370183 Free PMC article.
Reply.
Hagiwara S, Nishida N, Kudo M. Hagiwara S, et al. Hepatology. 2016 May;63(5):1744-5. doi: 10.1002/hep.27989. Epub 2015 Aug 25. Hepatology. 2016. PMID: 26175120 No abstract available.
Reply.
Hagiwara S, Nishida N, Kudo M. Hagiwara S, et al. Hepatology. 2016 Jul;64(1):306. doi: 10.1002/hep.28248. Epub 2015 Oct 30. Hepatology. 2016. PMID: 26403324 No abstract available.
Achievement of Complete Response and Drug-Free Status by Atezolizumab plus Bevacizumab Combined with or without Curative Conversion in Patients with Transarterial Chemoembolization-Unsuitable, Intermediate-Stage Hepatocellular Carcinoma: A Multicenter Proof-Of-Concept Study.
Kudo M, Aoki T, Ueshima K, Tsuchiya K, Morita M, Chishina H, Takita M, Hagiwara S, Minami Y, Ida H, Nishida N, Ogawa C, Tomonari T, Nakamura N, Kuroda H, Takebe A, Takeyama Y, Hidaka M, Eguchi S, Chan SL, Kurosaki M, Izumi N. Kudo M, et al. Among authors: hagiwara s. Liver Cancer. 2023 Feb 7;12(4):321-338. doi: 10.1159/000529574. eCollection 2023 Sep. Liver Cancer. 2023. PMID: 37901197 Free PMC article.
Severe Immune-Related Hepatitis Treated With Plasma Exchange.
Kanemura H, Hayashi H, Hagiwara S, Otani T, Haratani K, Yonesaka K, Ito A, Kudo M, Nakagawa K. Kanemura H, et al. Among authors: hagiwara s. J Thorac Oncol. 2020 Mar;15(3):e39-e42. doi: 10.1016/j.jtho.2019.11.014. J Thorac Oncol. 2020. PMID: 32093859 Free article. No abstract available.
163 results